{"id":469801,"date":"2026-02-10T03:57:10","date_gmt":"2026-02-10T03:57:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/469801\/"},"modified":"2026-02-10T03:57:10","modified_gmt":"2026-02-10T03:57:10","slug":"roche-details-non-inferiority-of-btk-inhibitor-in-multiple-sclerosis-trial-endpoints-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/469801\/","title":{"rendered":"Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial &#8211; Endpoints News"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMivAFBVV95cUxQZ3pSQnJTX0d1MWc2WENDTWltd1BybFRBSE5VSjNEZXczVjlKb3d1bmswenJPMnZWOG13S053emRDY3ppRkppSmpFVkxrQUFGbm9SNF9RMTNla1licWdnMjVuRVFoTURGMjYtRENlSnN5bkhPSTIzVVAwVlFGczdITmhJVFVYcjlkaWxzTXBIdmxnUEt5YjNkRFZFaTJWaWhiLUV1S19seElVR3h0TUFiMjZNZkU0bGRIckVjcg?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial<\/a>&nbsp;&nbsp;Endpoints News<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiigJBVV95cUxNUDMxd055cUZLYURUdzBMaWJMYWJOZEYwbExJaDRtcm4taVhaRWlnM3RJSmI4bUFka0dFVXQ5Mnh5Y19EQWFOWmhGUmxXZ25sQy1aX0t3UTlwRTlQNTBnLURJU2sxRWx4WDZUSmE3TkZCdi01NDBnMHE4S0hDazBOQWh4R2dkMkg3RnR6ZnlCVzcxaW54VV9TUnFoSzJaaHhoOC1yQXdxUjl2cGN3OVUtWWVvTnZudkJ4OUpkdk0wMktaQWYyVHN6X1lEdUVMb2RPcXAtUHBRQVo3VEFVOWtKNzV1Zmp2MFAzNWRrMmZYN1ZaRDZTX0U1dC1fOXV6Y1JpVlZVNFlUTHpLZw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">RO: Fenebrutinib matched ocrelizumab in slowing PPMS progression, with strong upper limb benefits<\/a>&nbsp;&nbsp;TradingView<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMikAJBVV95cUxOaDEyTVB4Z0d5RW9OOGFlZTE4WE1fVnRXbHliWFJQdmNCY2I0X0dfVG45Xy1mUmNJaE0tN0p1SmxodUw1aG9BUW03cHBkZ2N5TzhCNWx3dkRFQWNYNnNCVldQVFcxWTB5S253YmItcDYycTlkNC11YmdYeHQzY3BlRS1Rbjg4Z3otOG5WYjJkV0VLV2dzY2d3UkV5aUk3V1V2TURMUnZOT0I0Qkg4bXpGMWNTNXNsdUZZcWpBR2M1Rzc4NGVOMVloclh0cGlLQkhqTnNYb01tajlxQUdKaE5nQWRPMWdhTXdOZ1FmNHNZMnhIQUMzYXpLRG5Kd2JOTVRqWkdvYTlaUmZfSGJSZlpiTA?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">RO: Fenebrutinib demonstrated non-inferiority to OCREVUS in PPMS, reducing disability progression risk<\/a>&nbsp;&nbsp;TradingView<\/p>\n","protected":false},"excerpt":{"rendered":"Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial&nbsp;&nbsp;Endpoints NewsRO: Fenebrutinib matched ocrelizumab in slowing PPMS progression,&hellip;\n","protected":false},"author":2,"featured_media":469802,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,239952,239953,239955,137,490,15303,239951,53389,239950,21045,19839,174077,239954],"class_list":["post-469801","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-au","tag-australia","tag-btk-inhibitor","tag-fenebrutinib","tag-fentrepid","tag-health","tag-medication","tag-multiple-sclerosis","tag-ocrevus","tag-pharma","tag-ppms","tag-rd","tag-roche","tag-sanofi","tag-tolebrutinib"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/469801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=469801"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/469801\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/469802"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=469801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=469801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=469801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}